Vortex P5405KRecalls & reported problems
Navilyst Medical, Inc. · Vortex VX Single Titanium Port System with Attached 9.6F x 53cm Silicone Catheter · Class 2 · Implant
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI H787P5405K0), received between Jul 12, 2022 and Feb 26, 2026 — classified as 2 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Crack” (1 report).
2 other recalls cover devices cleared under the same FDA submission (K010189); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Crack1
- Material Puncture/Hole1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
- Pain1
- Rash1
- Swelling/ Edema1
- Thrombosis/Thrombus1
- Unspecified Infection1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryFeb 26, 2026Adverse Event Without Identified Device or Use Problem
ON OR ABOUT (B)(6) 2010, PLAINTIFF UNDERWENT PLACEMENT OF DEFENDANTS' VORTEX PORT CATHETER DEVICE, WITH MODEL NUMBER P5405K, AND LOT NUMBER 508180. THE VORTEX WAS IMPLANTED BY DR. (B)(6), M.D., (B)(6). THE PURPOSE OF IMPLANTATION OF THE VORTEX WAS TO ADMINISTER CHEMOTHERAPY TO TREAT PLAINTIFF'S LYMPHOMA. ON OR ABOUT (B)(6) 2014, PLAINTIFF PRESENTED TO (B)(6) WITH SYMPTOMS OF FACIAL AND UPPER NECK SWELLING, UPPER EXTREMITY SWELLING, AND RASH. PLAINTIFF SUBSEQUENTLY UNDERWENT A CT SCAN, WHICH REVEALED EVIDENCE OF THROMBUS SURROUNDING THE VORTEX PORT, REQUIRING REMOVAL OF THE DEVICE. ON OR ABOUT (B)(6) 2014, PLAINTIFF PRESENTED TO (B)(6) OUTPATIENT SURGERY IN (B)(6), TO UNDERGO REMOVAL OF DEFENDANTS' VORTEX DEVICE SECONDARY TO HER DEVELOPMENT OF THROMBOSIS AROUND THE PORT. THE REMOVAL PROCEDURE WAS PERFORMED BY (B)(6), M.D.
Patient problems: Rash; Swelling/ Edema; Thrombosis/Thrombus
MAUDE report 24465481 ↗InjuryJan 17, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON OR ABOUT (B)(6) 2018, PLAINTIFF UNDERWENT PLACEMENT OF THE ANGIODYNAMICS VORTEX PORT, REFERENCE NUMBER (B)(4), LOT NUMBER 5279951. THE DEVICE WAS IMPLANTED AT (B)(6) HOSPITAL IN (B)(6), FOR THE PURPOSE OF ONGOING CHEMOTHERAPY FOR CANCER. ON OR ABOUT (B)(6) 2019, PLAINTIFF PRESENTED HERSELF TO (B)(6) MEDICAL CENTER IN (B)(6) WHERE SHE WAS ADMITTED TO THE HOSPITAL DUE TO AN INFECTION. PLAINTIFF'S DOCTORS ULTIMATELY REMOVED THE PORT AND TREATED THE INFECTION. AS A RESULT OF HAVING THE VORTEX PORT IMPLANTED, PLAINTIFF HAS, ALLEGEDLY, EXPERIENCED SIGNIFICANT PAIN AND SUFFERING, HAS UNDERGONE ADDITIONAL SURGERIES, AND HAS SUFFERED FINANCIAL OR ECONOMIC LOSS, INCLUDING, BUT NOT LIMITED TO, OBLIGATIONS FOR MEDICAL SERVICES AND EXPENSES.
Patient problems: Unspecified Infection
MAUDE report 21180173 ↗MalfunctionDec 4, 2023Material Puncture/Hole; Material Puncture/Hole
AN END USER REPORTED AN ISSUE WITH A VORTEX SL TIT 9.6FR ATT SIL CATH W 10F INTR PG. IT WAS REPORTED THAT THE TUBE SYSTEM WAS FOUND TO BE LEAKING, ONCE THE PATIENT WAS RETURNED TO THEIR ROOM, DUE TO AN ACCIDENTAL PUNCTURE. IT IS BELIEVED THAT THE PUNCTURE "PROBABLY OCCURRED IN THE OPERATING ROOM DURING THE FIXATION OF THE DEVICE WITH SUTURE OR OTHERWISE COULD BE WHEN THE NURSE ADMINISTERED THE CHEMO TREATMENT THROUGH THE PORT." THE PORT WAS REMOVED AND REPLACED AND THE PATIENT DID NOT EXPERIENCE ANY ADVERSE EFFECTS OR HARM AS A RESULT OF THIS INCIDENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18255297 ↗MalfunctionJul 12, 2022Crack; Crack
AN ONCOLOGIST REPORTED AN ISSUE WITH A VTX SL TIT 9.6FR ATT SIL CATH W 10F INTR VORTEX PORT. THE PATIENT COMPLAINED OF PAIN DURING A CHEMOTHERAPY TREATMENT AND THE AREA TURNED RED. ULTIMATELY, THE PORT WAS REMOVED, AND UPON INSPECTION, A CRACK WAS OBSERVED IN THE SEPTUM. IT IS ASSUMED THAT THIS IS WHAT RESULTED IN THE EXTRAVASATION OF THE CHEMOTHERAPY AGENT. THE PORT'S FREQUENCY OF USE WAS REPORTED AS MONDAY THROUGH FRIDAY FOR THREE WEEKS. AFTER THE PORT REMOVAL THE PATIENT RECEIVED TREATMENT BY PERIPHERAL IV. IT WAS REPORTED THE PATIENT IS DOING WELL.
Patient problems: Pain
MAUDE report 14986645 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K010189. One submission often covers many models, so check the product and lot details in each record.
- Z-0402-2011 · Sep 27, 2010 · TerminatedVortex VX Port, AngioDynamics, Inc., One Horizon Way, Manchester, GA 31816
- Z-0149-2008 · Oct 3, 2007 · TerminatedVortex VX, Port System, 9.6FR, REF/Part Number : P5455K, Catalog Number: P5455, Latex Free, Sterile, AngioDynamics Incorporated, Manchester, GA. 31816
Other PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices
- PowerPort M.R.I., Groshong 9808560Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR3 deaths834 reports
- PowerPort ClearVUE 1608062Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR18 deaths571 reports
- PowerPort ClearVUE 5608062Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR31 deaths542 reports
- PowerPort M.R.I., ChronoFlex 1808000Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR19 deaths513 reports
- PowerPort M.R.I., ChronoFlex 1808060Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR1 recall15 deaths383 reports
- PowerPort M.R.I., Groshong 1808560Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR10 deaths304 reports
- PowerPort M.R.I., ChronoFlex 1829500Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR6 deaths197 reports
- BardPort M.R.I. 0602680Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR2 deaths179 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.